Literature DB >> 24462059

A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold.

Valérie Luyckx1, Marie-Madeleine Dolmans2, Julie Vanacker1, Camille Legat1, Cristina Fortuño Moya1, Jacques Donnez3, Christiani Andrade Amorim1.   

Abstract

OBJECTIVE: To create an artificial ovary to provide an alternative way of restoring fertility in patients who cannot benefit from transplantation of cryopreserved ovarian tissue due to the threat of reintroducing malignant cells.
DESIGN: In vivo experimental study.
SETTING: Gynecology research unit in a university hospital. ANIMAL(S): Six-week-old female NMRI mice. INTERVENTION(S): Autografting of isolated preantral follicles and ovarian cells (OCs) encapsulated in two fibrin matrices containing low concentrations of fibrinogen (F; mg/mL) and thrombin (T; IU/mL): F12.5/T1 and F25/T4. MAIN OUTCOME MEASURE(S): Follicular density and development, OC survival and proliferation, inflammatory response, and vascularization. RESULT(S): After 1 week, the follicle recovery rate ranged from 30.8% (F25/T4) to 31.8% (F12.5/T1). With both fibrin formulations, all follicles were found to be alive or minimally damaged, as demonstrated by terminal deoxynucleotide transferase-mediated dUTP nick-end labeling assay, and at the growing stage (primary, secondary, and antral follicles), confirmed by Ki67 immunostaining. Isolated OCs also survived and proliferated after grafting, as evidenced by <1% apoptotic cells and a high proportion of Ki67-positive cells. Vessels were found in both fibrin formulations, and the global vascular surface area varied from 1.35% (F25/T4) to 1.88% (F12.5/T1). Numerous CD45-positive cells were also observed in both F25/T4 and F12.5/T1 combinations. CONCLUSION(S): The present study is the first to show survival and growth of isolated murine ovarian follicles 1 week after autotransplantation of isolated OCs in a fibrin scaffold. The results indicate that fibrin is a promising candidate as a matrix for the construction of an artificial ovary. Xenotransplantation of isolated human follicles and OCs is the necessary next step to validate these findings.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Preantral follicles; artificial ovary; cancer patients; fertility preservation; fibrin; ovarian cells; transplantation

Mesh:

Substances:

Year:  2014        PMID: 24462059     DOI: 10.1016/j.fertnstert.2013.12.025

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  36 in total

Review 1.  The ovarian stroma as a new frontier.

Authors:  Hadrian M Kinnear; Claire E Tomaszewski; Faith L Chang; Molly B Moravek; Min Xu; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Reproduction       Date:  2020-09       Impact factor: 3.906

2.  Retrievable hydrogels for ovarian follicle transplantation and oocyte collection.

Authors:  Peter D Rios; Ekaterina Kniazeva; Hoi Chang Lee; Shuo Xiao; Robert S Oakes; Eiji Saito; Jacqueline S Jeruss; Ariella Shikanov; Teresa K Woodruff; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2018-05-14       Impact factor: 4.530

3.  Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?

Authors:  Michelle Soares; Pascale Saussoy; Karima Sahrari; Christiani A Amorim; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  J Assist Reprod Genet       Date:  2015-02-04       Impact factor: 3.412

4.  Minimal residual disease detection in cryopreserved ovarian tissue by multicolor flow cytometry in acute myeloid leukemia.

Authors:  Tristan Zver; Magalie Alvergnas-Vieille; Francine Garnache-Ottou; Christophe Ferrand; Christophe Roux; Clotilde Amiot
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

Review 5.  Ovarian regeneration: The potential for stem cell contribution in the postnatal ovary to sustained endocrine function.

Authors:  Alisha M Truman; Jonathan L Tilly; Dori C Woods
Journal:  Mol Cell Endocrinol       Date:  2016-10-12       Impact factor: 4.102

Review 6.  Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice.

Authors:  Mahmoud Salama; Teresa K Woodruff
Journal:  Expert Rev Anticancer Ther       Date:  2017-06-05       Impact factor: 4.512

7.  The Effects of Negative Elements in Environment and Cancer on Female Reproductive System.

Authors:  Jiangxue Qu; Yuehan Li; Shujie Liao; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  A novel fibrin-based artificial ovary prototype resembling human ovarian tissue in terms of architecture and rigidity.

Authors:  Maria Costanza Chiti; Marie-Madeleine Dolmans; Lucie Mortiaux; Flanco Zhuge; Emna Ouni; Parinaz Asiabi Kohneh Shahri; Evelyne Van Ruymbeke; Sophie-Demoustier Champagne; Jacques Donnez; Christiani Andrade Amorim
Journal:  J Assist Reprod Genet       Date:  2017-12-13       Impact factor: 3.412

9.  Fibrin-mediated delivery of an ovarian follicle pool in a mouse model of infertility.

Authors:  Rachel M Smith; Ariella Shikanov; Ekaterina Kniazeva; Deepa Ramadurai; Teresa K Woodruff; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2014-06-12       Impact factor: 3.845

10.  In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe.

Authors:  Ingrid Segers; Ileana Mateizel; Ellen Van Moer; Johan Smitz; Herman Tournaye; Greta Verheyen; Michel De Vos
Journal:  J Assist Reprod Genet       Date:  2015-08-08       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.